MacroLensNP नेपालीने Sign in Create accountSign up
Free · Life Insurance

LICN Life Insurance Co. Nepal

Rs 799.00 +2.10 (+0.26%) as of 2026-11-06 15:00:00
Open
799.00
High
799.80
Low
795.00
Prev. close
796.90
Volume
1,458
Turnover
11.65 lakh
Avg volume (30 d)
10,035
52-week low Rs 741.50
high Rs 969.00 -17.5% from the 52-week high

Life Insurance Co. Nepal (LICN) is listed on the Nepal Stock Exchange in the Life Insurance sector. Its share price is Rs 799.00 as of 6 November 2026, 17.5% below its 52-week high of Rs 969.00 and 7.8% above its 52-week low of Rs 741.50. It trades at a P/E of 108.3 on earnings per share of Rs 7.38, more expensive than the Life Insurance sector's median P/E of 56.6.

LICN paid a dividend in 5 of the last 8 fiscal years we track; the latest was 21.05% cash for FY 2081/2082. Promoters hold 67% of the shares and the public 33%.

Key figures latest report 2082/2083 Q4

Market value
4,395 crore · 43.95 arba
Shares listed
55,000,000
Paid-up capital
550.00 crore · 5.50 arba
EPS (annualised)
Rs 7.38
P/E
108.3
Book value / share
Rs 177.87
P/B
4.49
ROE
4.2%
ROA
0.25%
Dividend yield
2.63%
Net profit (annualised)
40.58 crore
Reserves
–
Total assets
15,930 crore · 1.59 kharab
Debt to equity
15.28

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 7.38 +28.5% 40.58 crore 2,125 crore · 21.25 arba 4.1%
2082/2083 Q3 7.28 +41.9% 40.03 crore 2,107 crore · 21.07 arba 4.0%
2082/2083 Q2 7.25 +63.6% 39.86 crore 2,071 crore · 20.71 arba 4.1%
2082/2083 Q1 6.28 +34.1% 34.54 crore 2,035 crore · 20.35 arba 3.6%
2081/2082 Q4 5.74 +32.5% 31.59 crore 1,994 crore · 19.94 arba 3.4%
2081/2082 Q3 5.13 +20.9% 28.21 crore 1,925 crore · 19.25 arba 3.3%
2081/2082 Q2 4.43 +49.9% 24.37 crore 1,890 crore · 18.90 arba 3.2%
2081/2082 Q1 4.68 +35.4% 25.76 crore 1,817 crore · 18.17 arba 3.7%

Dividends

Fiscal yearBonusCashBook close
2081/2082– 21.05% 1 Jan 2026
2080/208110.00% 0.53% 30 Jun 2025
2079/2080– – –
2078/2079– – –
2077/2078– – –
2076/207720.00% 1.05% 7 Feb 2022
2075/207610.00% 0.53% 19 Feb 2021
2074/207534.46% 35.53% 25 Jul 2019

Bonus / right shares: Jun 2025 Bonus share 10% · Oct 2024 Right share 1:0.88 at Rs 100 · Feb 2022 Bonus share 20%

Who owns it

Promoters 67% Public 33%
Public float
17,963,000 shares
Mutual funds hold
2.8% of the float
Promoter lock-in
–

MacroLens analysis of LICN

More on LICN on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Life Insurance companies

CompanyPriceTodayP/EP/BMarket value
NLIC Nepal Life Insurance Co. Ltd. 740.00 +0.14% 150.75.87 7,015 crore · 70.15 arba
NLICL National Life Insurance Co. Lt... 580.00 -0.17% 89.14.54 3,301 crore · 33.01 arba
HLI Himalayan Life Insurance Limit... 303.00 -0.10% 87.13.25 2,770 crore · 27.70 arba
RNLI Reliable Nepal Life Insurance... 446.00 -0.67% 39.83.00 2,318 crore · 23.18 arba
PMLI Prabhu Mahalaxmi Life Insuranc... 429.00 +0.37% 60.63.68 2,277 crore · 22.77 arba
ALICL Asian Life Insurance Co. Limit... 422.20 -0.42% 53.53.51 2,217 crore · 22.17 arba
ILI IME Life Insurance Company Lim... 443.00 +0.07% 37.93.27 2,215 crore · 22.15 arba
CLI Citizen Life Insurance Company... 442.00 +0.34% 56.53.36 2,210 crore · 22.10 arba

Every Life Insurance company 14

Browse all NEPSE stocks by sector →

LICN: common questions

What is the share price of LICN today?

LICN (Life Insurance Co. Nepal) closed at Rs 799.00 as of 6 November 2026 on NEPSE.

Does LICN pay dividends?

LICN paid a dividend in 5 of the last 8 fiscal years we track; the latest was 21.05% cash for FY 2081/2082.

What is the P/E ratio of LICN?

It trades at a P/E of 108.3 on earnings per share of Rs 7.38, more expensive than the Life Insurance sector's median P/E of 56.6.

Is LICN a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - LICN's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.